IP Library Granted Patent US 7,595,279
Granted Patent B2
US 7,595,279 · App. 10/947,095 · Granted Sep 29, 2009

Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,595,279
App. No.
10/947,095
Granted
Sep 29, 2009
Kind
B2
Abstract

A polyelectrolyte having multiple exposed functional groups, each such group being capable of covalently bonding to a molecule, is immobilized on a surface for the purpose of bonding to a biomolecule. The biomolecule can be, for example, a nucleic acid, e.g., an amine functionalized oligonucleotide. The polyelectrolyte can include, e.g., BSA (Bovine Serum Albumin) which is bound to a functionalized surface using a covalent immobilization strategy, e.g., reaction with the surface of a tosyl-activated microparticle. Following such reaction, exposed reactive functional groups on the protein, such as amine, carboxyl, thiol, hydroxyl groups can further be utilized to covalently couple the oligonucleotide of interest using suitable chemistry.

Claims (17)

1. A method of producing a solid microparticle having nucleic acid molecules attached, said microparticle being made of a polymer, a polymer resin, glass or latex, wherein a surface of the microparticle is coated with Bovine Serum Albumin under conditions whereby the Bovine Serum Albumin has an increased number sites for covalent attachment of nucleic acid molecules, comprising:

covalently attaching Bovine Serum Albumin to said surface at a temperature of about 65° C.; and

covalently attaching nucleic acid molecules to said Bovine Serine Albumin.

2. The method of claim 1 wherein the nucleic acid is attached to the Bovine Serum Albumin through the Bovine Serum Albumin carboxyl or amine groups.

3. The method of claim 1 wherein the nucleic acid is an oligonucleotide.

4. The method of claim 1 wherein the nucleic acid molecules are bound to the Bovine Serum Albumin through an amide linkage, formed by an 1-ethyl-3-(3-imethylaminopropyl) carbodiimide reaction.

5. The method of claim 1 wherein the surface of the microparticle is activated with tosyl.

6. The method of claim 3 wherein the oligonucleotide is DNA, RNA, a peptide nucleic acid, a locked nucleic acid, or mixtures thereof.

7. The method of claim 3 wherein the oligonucleotide is modified at its 3′ or 5′ end with a functional group.

8. The method of claim 7 wherein the functional group is a primary amino group.

9. A method of making a support coated with macromolecules in a first configuration capable of altering their conformation and exposing an increased number of covalent binding sites in response to an increase in temperature and capable of covalently binding oligonucleotides, comprising:

adsorbing to the support, at a first temperature, said macromolecules in said first configuration; and

covalently attaching the adsorbed macromolecules to the support at a second temperature at which said adsorbed macromolecules change to a second conformation in which additional sites for covalent binding of oligonucleotides are exposed.

10. The method of claim 9 wherein a single layer of the macromolecules are adsorbed to the support.

11. The method of claim 9 wherein the macromolecules are selected from the group consisting of protein, polypeptide and glycoprotein.

12. The method of claim 11 wherein the protein is bovine serum albumin.

13. The method of claim 9 wherein the support is a microparticle.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Mar 15, 2023
From: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS, INC.
Reel/Frame 063090/0033 →
RELEASE OF SECURITY INTEREST Recorded Mar 15, 2023
From: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS, INC.
Reel/Frame 063090/0111 →
SECURITY INTEREST Recorded Jul 2, 2020
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 053119/0135 →
SECURITY INTEREST Recorded Jul 2, 2020
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS INC.
To: ALTER DOMUS (US) LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 053119/0152 →
RELEASE OF PATENT SECURITY INTERESTS Recorded Jul 2, 2020
From: CITIBANK, N.A.
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; IMMUCOR GTI DIAGNOSTICS, INC.; SIRONA GENONICS, INC.
Reel/Frame 053121/0935 →
PATENT SECURITY AGREEMENT Recorded Aug 19, 2011
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026778/0640 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2010
From: WANG, XINWEN; BANERJEE, SUKANTA
To: BIOARRAY SOLUTIONS LTD.
Reel/Frame 025464/0241 →